According to the Zhitong Finance App, Peijia Medical-B (09996.HK) issued an announcement. On December 11, 2025, the company received approval from the State Drug Administration of the People's Republic of China for the registration application for the TaurusRio™ transcatheter aortic valve (TAV) system.

According to the Zhitong Finance App, Peijia Medical-B (09996.HK) issued an announcement. On December 11, 2025, the company received approval from the State Drug Administration of the People's Republic of China for the registration application for the TaurusRio™ transcatheter aortic valve (TAV) system.